IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6511-6519

  Isla Larrain, M T ^a   Rabassa, M E ^a   Lacunza, E ^a   Barbera, A ^b   Creton A ^b   Segal Eiras, A ^a   Croce, M V ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Breast Clinic   (Argentina)

Author keywords

Breast cancer; Gene expression; IDO; Immune tolerance; Microvesicles

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; PROGESTERONE RECEPTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; CELL PROLIFERATION; CENTRIFUGATION; COMPUTER MODEL; CONTROLLED STUDY; CYTOPLASM VESICLE; ELECTRON MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; METASTASIS; MICROVESICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIPLE NEGATIVE BREAST CANCER; ULTRACENTRIFUGATION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; COMPUTER SIMULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MCF-7 CELLS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84904999099     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1859-3     Document Type: Article

References (23)

1. Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today. 1999;20(10):469-73. (Pubitemid 29476077)
2. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med. 1999;189(9):1363-72. (Pubitemid 29227522)
3. Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 1991;5(11):2516-22. Review. (Pubitemid 21905800)
4. Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest. 2007;117(5):1147-54. Review. (Pubitemid 46718399)
5. Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Mellor AL, Munn DH, Blazar BR. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood. 2009;114(24):5062-70.
6. Munn DH, Mellor AL. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol. 2013;34(3):137-43. doi:10.1016/j.it.2012.10. 001.
7. Bauer TM, Jiga LP, Chuang JJ, Randazzo M, Opelz G, Terness P. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl Int. 2005;18(1):95-100. (Pubitemid 41742952)
8. Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol. 2004;5(10):996-1002. Review. (Pubitemid 41057716)
9. Bauernhofer T, Kuss I, Henderson B, Baum AS, Whiteside TL. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur J Immunol. 2003;33(1):119-24. (Pubitemid 36157649)
10. Song H, Park H, Kim YS, Kim KD, Lee HK, Cho DH, et al. L-kynurenine-induced apoptosis in human NK cells is mediated by reactive oxygen species. Int Immunopharmacol. 2011;11(8):932-8.
11. Whiteside TL. Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? Br J Cancer. 2005;92(2):209-11. (Pubitemid 40343129)
12. Croce MV, Isla-Larrain MT, Demichelis SO, Gori JR, Price MR, Segal-Eiras A. Tissue and serum MUC1 mucin detection in breast cancer patients. Breast Cancer Res Treat. 2003;81(3):195-207. (Pubitemid 37352457)
13. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4. (Pubitemid 9256559)
14. Chen X, Li J, Gray WH, Lehmann BD, Bauer JA, Shyr Y, et al. TNBCtype: a subtyping tool for triple-negative breast cancer. Cancer Informat. 2012;11:147-56. doi:10.4137/CIN.S9983.
15. Sabatier R, Finetti P, Cervera N, Lambaudie E, et al. A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Res Treat. 2011;126(2):407-20. PMID: 20490655.
16. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750-67. doi:10.1172/JCI45014.
17. Wang H, Pan K, Xia JC. Interaction of indoleamine-2,3-dioxygenase and CD4+CD25+ regulatory T cells in tumor immune escape. Ai Zheng. 2009;28(2):184-7. Review.
18. Munn DH. Blocking IDO, activity to enhance anti-tumor immunity. Front Biosci (Elite Ed). 2012;4:734-45. Review.
19. Yu J, Sun J, Wang SE, Li H, Cao S, Cong Y, et al. Upregulated expression of indoleamine 2,3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis. Clin Dev Immunol. 2011;2011:469135. doi:10.1155/2011/469135.
20. Jacquemier J, Bertucci F, Finetti P, Esterni B, Charafe-Jauffret E, Thibult ML, et al. High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma. Int J Cancer. 2012;130(1):96-104. doi:10.1002/ijc.25979.
21. Soliman H, Rawal B, Fulp J, Lee JH, Lopez A, Bui MM, et al. Analysis of indoleamine 2,3-dioxygenase (IDO 1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunol Immunother. 2013;62(5):829-37. doi:10.1007/s00262-013-1393-y.
22. Taylor DD, Gerçel-Taylor C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer. 2005;92(2):305-11. (Pubitemid 40343146)
23. Whiteside TL. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem Soc Trans. 2013;41(1):245-51. doi:10.1042/BST20120265. Review.